Brian Metz, MD
Otolaryngology · Olathe, KSNPI 1598761520
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Aerin Medical Inc. at 33.6% of the total. Reporting peaked in 2024 at $492 and has fallen 58.5% since, to $204 in 2025.
Across 68 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$552
- Medtronic$256
- Sanofi$227
- Optinose US, Inc.$131
- AbbVie$86
- Smith+Nephew$76
- plus $315 from 14 others
What the payments were for
- Food & beverage$1,643100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 25 | $552 |
| Medtronic | 2 | $256 |
| Sanofi | 10 | $227 |
| Optinose US, Inc. | 6 | $131 |
| AbbVie | 5 | $86 |
| Smith+Nephew | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Acclarent, Inc | 2 | $45 |
| Alk-abello, Inc | 2 | $43 |
| Merck | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Greer Laboratories, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Stryker | 1 | $11 |
| Kaleo, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$256
How this compares
$1,643 in reported general payments places this provider in the 55th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 180 | $4,749 |
| SynthroidLevothyroxine Sodium | 16 | $2,088 |
| Pilocarpine Hcl | 16 | $974 |
| Famotidine | 99 | $906 |
| Amitriptyline Hcl | 47 | $704 |
| Fluocinolone Acetonide Oil | 17 | $603 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 64 | $563 |
| Azelastine Hcl | 20 | $394 |
| Mupirocin | 51 | $368 |
| Pantoprazole Sodium | 66 | $363 |
| Ofloxacin | 36 | $353 |
| Clindamycin Hcl | 27 | $228 |
| Omeprazole | 13 | $215 |
| Prednisone | 91 | $163 |
| Levothyroxine Sodium | 19 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $86 | $2,08816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 87 otolaryngology providers in Kansas.
Other otolaryngology in Olathe
- David HillOlathe$5K
- Bruce ZimmermanOlathe$758
- Hinrich StaeckerKansas City$499K
- Stanley McClurgMerriam$133K
- Douglas CowanLeawood$32K
- Jennifer VillwockKansas City$26K
- David RudmanOverland Park$18K
- Nicholas WirtzMerriam$14K
- Meha FoxKansas City$12K
- Kiran KakaralaKansas City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.